<div class="lightbox-header">
    <h2 class="title">MARK CAULFIELD</h2>
    <p>Medical Advisory Group Lead: Director of the William Harvey Research Institute, Director of Barts and The London NIHR Cardiovascular Biomedical Research Unit<p>
</div>
<div class="lightbox-body">
    <img alt="Profile photo of Mark Caulfield" src="../../../public/cms/150/318/47/1787/m4xa9Z_web.jpg" width="140" height="140" />
    <p><span style="font-size: small;"><strong></strong>Mark Caulfield graduated as a doctor of medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew&rsquo;s Hospital where he developed a research programme in molecular genetics of hypertension and clinical study of new therapies for blood pressure and cholesterol. He was appointed Director of William Harvey Research Institute at Queen Mary University of London in 2002 which is the UK&rsquo;s largest pharmacological institute with over 350 clinicians and scientists working on cardiovascular disease, inflammation and endocrine disorders.. Since 2008 he directs the Barts National Institute of Health Research Cardiovascular Biomedical Research Unit. and was elected to the Academy of Medical Sciences in 2008. He was President of the British Hypertension Society (2009-2011) and led on fundraising towards the &pound;25m William Harvey Heart Centre which created a translational clinical research centre. He served on the NICE Guideline Group for hypertension published in 2011 and leads the Joint UK Societies&rsquo; Working Group and Consensus on Renal Denervation.</span></p>    </div>